Related Experiment Video
Updated: Jun 28, 2026

08:49
A 3D Organotypic Melanoma Spheroid Skin Model
Published on: May 18, 2018
Unexpected melanoma metastasis with E-cadherin expression in bone marrow
1Anatomy and Pathological Histology Unit, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy. marco.pocci@iov.veneto.it.
Journal of Hematopathology
|June 26, 2026
Summary
Unexpected melanoma metastasis can be mistaken for leukemia in bone marrow biopsies. E-cadherin expression, typically used for red blood cells, can also indicate melanoma, highlighting its importance in differential diagnosis.
Area of Science:
- Hematopathology
- Oncology
- Immunohistochemistry
Background:
- Bone marrow biopsy (BMB) is crucial for diagnosing hematological disorders.
- Unexpected findings in BMB can lead to diagnostic challenges.
- E-cadherin expression is a common marker in hematopathology but can be expressed by other neoplasms.
Purpose of the Study:
- To report a case of melanoma metastasis mimicking hematological malignancy in BMB.
- To emphasize the diagnostic implications of E-cadherin expression in atypical cells found in BMB.
- To highlight the importance of considering melanoma in the differential diagnosis of E-cadherin-positive neoplasms.
Main Methods:
- Morphological evaluation of bone marrow biopsy.
- Immunohistochemical staining for E-cadherin and other markers.
- Review of patient history including suspected acute leukemia and myelofibrosis.
Main Results:
- Atypical cells with E-cadherin expression were identified in a BMB.
- These cells were diagnosed as melanoma metastasis, not acute leukemia.
- E-cadherin expression was confirmed in the metastatic melanoma cells.
Conclusions:
- E-cadherin expression in BMB is not exclusive to erythroid cells and can be seen in melanoma metastasis.
- Melanoma should be included in the differential diagnosis when E-cadherin-positive atypical cells are found in BMB.
- Careful morphological and immunohistochemical evaluation is essential for accurate diagnosis in challenging BMB cases.

